Beyer M - Search Results

1

Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in Sézary syndrome.

Steinhoff M, Schöpp S, Assaf C, Muche M, Beyer M, Sterry W, Lukowsky A. Steinhoff M, et al. Among authors: beyer m. Leuk Res. 2009 Jan;33(1):88-99. doi: 10.1016/j.leukres.2008.06.025. Epub 2008 Jul 30. Leuk Res. 2009. PMID: 18672285

2

The treatment of mycosis fungoides.

Mestel DS, Beyer M, Steinhoff M, Sterry W, Assaf C. Mestel DS, et al. Among authors: beyer m. G Ital Dermatol Venereol. 2008 Dec;143(6):395-408. G Ital Dermatol Venereol. 2008. PMID: 19169212 Review.

3

Treatment of cutaneous lymphomas: today and tomorrow.

Mestel DS, Beyer M, Steinhoff M, Sterry W. Mestel DS, et al. Among authors: beyer m. Actas Dermosifiliogr. 2009 Nov;100 Suppl 1:18-32. doi: 10.1016/s0001-7310(09)73165-5. Actas Dermosifiliogr. 2009. PMID: 20096194

4

Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.

Braun FC, Grabarczyk P, Möbs M, Braun FK, Eberle J, Beyer M, Sterry W, Busse F, Schröder J, Delin M, Przybylski GK, Schmidt CA. Braun FC, et al. Among authors: beyer m. Leukemia. 2011 Sep;25(9):1494-501. doi: 10.1038/leu.2011.101. Epub 2011 May 31. Leukemia. 2011. PMID: 21625233

5

Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate.

Steinhoff M, Beyer M, Roewert-Huber J, Lukowsky A, Assaf C, Sterry W. Steinhoff M, et al. Among authors: beyer m. J Am Acad Dermatol. 2008 May;58(5 Suppl 1):S88-91. doi: 10.1016/j.jaad.2007.07.012. J Am Acad Dermatol. 2008. PMID: 18489056

6

Dominance of nonmalignant T-cell clones and distortion of the TCR repertoire in the peripheral blood of patients with cutaneous CD30+ lymphoproliferative disorders.

Humme D, Lukowsky A, Steinhoff M, Beyer M, Walden P, Sterry W, Assaf C. Humme D, et al. Among authors: beyer m. J Invest Dermatol. 2009 Jan;129(1):89-98. doi: 10.1038/jid.2008.204. Epub 2008 Jul 17. J Invest Dermatol. 2009. PMID: 18633437 Free article.

7

Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B-cell lymphomas: first results of a prospective, monocentre study.

Maza S, Gellrich S, Assaf C, Beyer M, Spilker L, Orawa H, Munz DL, Sterry W, Steinhoff M. Maza S, et al. Among authors: beyer m. Leuk Lymphoma. 2008 Sep;49(9):1702-9. doi: 10.1080/10428190802258923. Leuk Lymphoma. 2008. PMID: 18661405 Clinical Trial.

8

Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome.

Mestel DS, Beyer M, Möbs M, Steinhoff M, Sterry W, Assaf C. Mestel DS, et al. Among authors: beyer m. Expert Opin Biol Ther. 2008 Dec;8(12):1929-39. doi: 10.1517/14712590802528696. Expert Opin Biol Ther. 2008. PMID: 18990079 Review.

9

T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor clone.

Humme D, Lukowsky A, Gierisch M, Haider A, Vandersee S, Assaf C, Sterry W, Möbs M, Beyer M. Humme D, et al. Among authors: beyer m. Exp Dermatol. 2014 Jul;23(7):504-8. doi: 10.1111/exd.12453. Exp Dermatol. 2014. PMID: 24862432

10

Emerging drugs in cutaneous T cell lymphoma.

Mestel DS, Assaf C, Steinhoff M, Beyer M, Moebs M, Sterry W. Mestel DS, et al. Among authors: beyer m. Expert Opin Emerg Drugs. 2008 Jun;13(2):345-61. doi: 10.1517/14728214.13.2.345. Expert Opin Emerg Drugs. 2008. PMID: 18537525 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

852 results

Search Page

Filters